New report reveals need for a gender-based approach to health funding for women to have full economic empowerment

Allergan

30 November 2017 - Recent CADTH recommendation to improve access to oral uterine fibroids treatment presents positive step forward in helping women stay in the workforce.

As large-scale demographic trends impact the age and composition of the Canadian population and workforce, action must be taken to ensure women can fully and successfully contribute to the economy. A joint white paper released today argues that a gender-based approach to public health funding should be implemented for women to have better treatment access that prevents work absenteeism.

Co-authored by Canadian Women with Fibroids, Women's Health Coalition, Women's Health Initiative Network and Allergan, the paper contains new data from surveys of Ontario employers and the provincial policy community. Eighty-five per cent of public and private sector employers agree that more must be done to address the unique barriers and challenges women face to fully participate in the workforce.

Read Allergan press release

Michael Wonder

Posted by:

Michael Wonder